Preclinical data demonstrate genetic and epigenetic reprogramming can ameliorate T cell exhaustion and enhance stem-like qualities and potency of T cells in various modalities “Our SITC presentations ...
MILAN, Italy and NEW YORK, Feb. 08, 2024 (GLOBE NEWSWIRE) -- Genenta Science (GNTA), a clinical-stage immuno-oncology (I/O) company developing a cell-based platform harnessing the power of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback